COVID-19 Collection

Journal article : Correspondence

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Selim, R., Wellens, J., Brann, S., Marlow, L., Adams, A., & Satsangi, J. J. (2022). Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy. Lancet Gastroenterology and Hepatology, 7(11), 984–985.

MLA Style

Selim, R, et al. “Decrease in Uptake of SARS-CoV-2 Vaccine in Patients with Inflammatory Bowel Disease on Intravenous Biological Therapy.” Lancet Gastroenterology and Hepatology, vol. 7, no. 11, 2022, pp. 984–85.

Chicago Style

Selim, R, J Wellens, S Brann, L Marlow, A Adams, and JJ Satsangi. 2022. “Decrease in Uptake of SARS-CoV-2 Vaccine in Patients with Inflammatory Bowel Disease on Intravenous Biological Therapy.” Lancet Gastroenterology and Hepatology 7 (11): 984–85.
Print

Access Document

Publisher copy:: 10.1016/s2468-1253(22)00302-8

Authors

+ Selim, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Research group:: Translational Gastroenterology Unit
Role:: Author

+ Wellens, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Research group:: Translational Gastroenterology Unit
Role:: Author

+ Brann, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: NDM Experimental Medicine
Research group:: Translational Gastroenterology Unit
Role:: Author

+ Marlow, L More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Research group:: Translational Gastroenterology Unit
Role:: Author

+ Adams, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: NDM Experimental Medicine
Research group:: Translational Gastroenterology Unit
Role:: Author
ORCID:: 0000-0001-9364-8540

More authors...

+ National Institute for Health and Care Research More from this funder

Funder identifier:: https://ror.org/0187kwz08

Publisher:: Elsevier
Journal:: Lancet Gastroenterology and Hepatology More from this journal
Volume:: 7
Issue:: 11
Pages:: 984-985
Place of publication:: Netherlands
Publication date:: 2022-09-22
Acceptance date:: 2022-09-01
DOI:: 10.1016/s2468-1253(22)00302-8
EISSN:: 2468-1253
ISSN:: 2468-1253
Pmid:: 36152635

Language:: English
Subtype:: Correspondence
Pubs id:: 1279884
UUID:: uuid_1b0d2588-c4d0-4b74-b9c7-bb57cb0ff1ea
Local pid:: pubs:1279884
Source identifiers:: W4296628374
Deposit date:: 2026-01-23
ARK identifier:: ark:/29072/ora_1b0d2588c4d04b74b9c7bb57cb0ff1ea

Terms of use

Copyright holder:: Elsevier Ltd.
Copyright date:: 2022
Rights statement:: © 2022 Elsevier Ltd. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP